Tomii K - Search Results

1

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.

Fujimoto D, Miura S, Tomii K, Sumikawa H, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Kijima T, Asao T, Tamiya M, Nakamura A, Yoshioka H, Tokito T, Murakami S, Tamiya A, Yokouchi H, Watanabe S, Yamaguchi O, Morinaga R, Jodai T, Ito K, Shiraishi Y, Kogure Y, Shibaki R, Yamamoto N. Fujimoto D, et al. Among authors: tomii k. Sci Rep. 2023 Mar 6;13(1):3698. doi: 10.1038/s41598-023-30676-y. Sci Rep. 2023. PMID: 36878936 Free PMC article.

2

Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.

Maruyama R, Nishiwaki Y, Tamura T, Yamamoto N, Tsuboi M, Nakagawa K, Shinkai T, Negoro S, Imamura F, Eguchi K, Takeda K, Inoue A, Tomii K, Harada M, Masuda N, Jiang H, Itoh Y, Ichinose Y, Saijo N, Fukuoka M. Maruyama R, et al. Among authors: tomii k. J Clin Oncol. 2008 Sep 10;26(26):4244-52. doi: 10.1200/JCO.2007.15.0185. J Clin Oncol. 2008. PMID: 18779611 Clinical Trial.

3

[Lobectomy for local recurrence following stereotactic radiotherapy to non-small cell lung cancer].

Neri S, Kitamura J, Komatsu T, Takahashi Y, Takeshima Y, Kaji R, Hayashi M, Nishimura T, Tomii K, Katakami N, Ishihara K, Kokubo M. Neri S, et al. Among authors: tomii k. Kyobu Geka. 2009 Aug;62(9):812-5. Kyobu Geka. 2009. PMID: 19670785 Japanese.

4

Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.

Ishii H, Trapnell BC, Tazawa R, Inoue Y, Akira M, Kogure Y, Tomii K, Takada T, Hojo M, Ichiwata T, Goto H, Nakata K; Japanese Center of the Rare Lung Disease Consortium. Ishii H, et al. Among authors: tomii k. Chest. 2009 Nov;136(5):1348-1355. doi: 10.1378/chest.09-0097. Chest. 2009. PMID: 19892674

5

Complex mutations in the epidermal growth factor receptor gene in non-small cell lung cancer.

Hata A, Yoshioka H, Fujita S, Kunimasa K, Kaji R, Imai Y, Tomii K, Iwasaku M, Nishiyama A, Ishida T, Katakami N. Hata A, et al. Among authors: tomii k. J Thorac Oncol. 2010 Oct;5(10):1524-8. doi: 10.1097/JTO.0b013e3181e8b3c5. J Thorac Oncol. 2010. PMID: 20808254 Free article.

6

Amrubicin at a lower-dose with routine prophylactic use of granulocyte-colony stimulating factor for relapsed small-cell lung cancer.

Hata A, Katakami N, Fujita S, Kaji R, Nanjo S, Otsuka K, Kida Y, Higashi Y, Tachikawa R, Hayashi M, Nishimura T, Tomii K. Hata A, et al. Among authors: tomii k. Lung Cancer. 2011 May;72(2):224-8. doi: 10.1016/j.lungcan.2010.08.009. Epub 2010 Sep 9. Lung Cancer. 2011. PMID: 20828862

7

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selection.

Hata A, Katakami N, Yoshioka H, Fujita S, Kunimasa K, Nanjo S, Otsuka K, Kaji R, Tomii K, Iwasaku M, Nishiyama A, Hayashi H, Morita S, Ishida T. Hata A, et al. Among authors: tomii k. Lung Cancer. 2011 Nov;74(2):268-73. doi: 10.1016/j.lungcan.2011.03.010. Epub 2011 May 6. Lung Cancer. 2011. PMID: 21529987

8

Erlotinib for pretreated squamous cell carcinoma of the lung in Japanese patients.

Hata A, Katakami N, Kunimasa K, Yoshioka H, Fujita S, Kaji R, Tachikawa R, Tomii K, Imai Y, Iwasaku M, Ishida T. Hata A, et al. Among authors: tomii k. Jpn J Clin Oncol. 2011 Dec;41(12):1366-72. doi: 10.1093/jjco/hyr159. Epub 2011 Nov 3. Jpn J Clin Oncol. 2011. PMID: 22058419

9

Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial.

Fujita S, Katakami N, Masago K, Yoshioka H, Tomii K, Kaneda T, Hirabayashi M, Kunimasa K, Morizane T, Mio T. Fujita S, et al. Among authors: tomii k. BMC Cancer. 2012 May 21;12:185. doi: 10.1186/1471-2407-12-185. BMC Cancer. 2012. PMID: 22613958 Free PMC article. Clinical Trial.

10

Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902.

Kim YH, Hirabayashi M, Togashi Y, Hirano K, Tomii K, Masago K, Kaneda T, Yoshimatsu H, Otsuka K, Mio T, Tomioka H, Suzuki Y, Mishima M. Kim YH, et al. Among authors: tomii k. Cancer Chemother Pharmacol. 2012 Aug;70(2):271-6. doi: 10.1007/s00280-012-1910-2. Epub 2012 Jun 30. Cancer Chemother Pharmacol. 2012. PMID: 22752216 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page